INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 November 2014
Net Assets |
£203m |
Net Assets per share |
476p |
Share price |
415p |
Total value of unquoted investments |
£18m |
Total number of portfolio companies |
82 |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
9.8 |
Gilead |
6.4 |
Regeneron |
6.1 |
Chimerix |
5.1 |
Alexion |
5.0 |
Amgen |
4.8 |
Biogen-Idec |
4.2 |
Illumina |
3.6 |
Mylan |
3.1 |
Biomarin |
3.0 |
|
----------- |
Total |
51.1 |
Portfolio Profitability |
% NAV |
Profitable |
57 |
Turning Profitable 2015 |
7 |
Unprofitable |
36 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
US & Canada |
90 |
Europe & UK |
10 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
91 |
Unquoted |
9 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
22 DECEMBER 2014